Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment

By Joo Moon Kyung   Yeon Jong Eun   Kim Ji Hoon   Jung Young Kul   Lee Sun Jae   Kim Jeong Han   Yim Hyung Joon   Byun Kwan Soo   Park Jong-Jae   Kim Jae Seon   Bak Young-Tae  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 12, 2008-01 ,pp. : 1514-1521

Informa Healthcare

Access to resources Recommend Favorite

Erratum to: Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B

By Karino Yoshiyasu  

Hepatology International, Vol. 4, Iss. 4, 2010-12 ,pp. : 789-790

Springer Publishing Company

Access to resources Recommend Favorite

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

By Sato Ken   Takagi Hitoshi   Kakizaki Satoru   Sohara Naondo   Mori Masatomo  

Journal of Gastroenterology, Vol. 41, Iss. 3, 2006-03 ,pp. : 283-285

Springer Publishing Company

Access to resources Recommend Favorite

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

By Sato Ken   Takagi Hitoshi   Kakizaki Satoru   Sohara Naondo   Mori Masatomo  

Journal of Gastroenterology, Vol. 41, Iss. 9, 2006-09 ,pp. : 927-927

Springer Publishing Company

Access to resources Recommend Favorite

Association Between Polymorphism of Tumor Necrosis Factor-α Promoter and Response to Lamivudine Treatment in Patients with Chronic Hepatitis B

By Park Yong   Lee Jung   Kim Do   Chang Hye   Kim Ja   Lee Chun   Park Jun   Ahn Sang   Lee Kwan   Han Kwang  

Digestive Diseases and Sciences, Vol. 55, Iss. 7, 2010-07 ,pp. : 2043-2048

Springer Publishing Company

Access to resources Recommend Favorite